Valeo Financial Advisors, LLC Novartis Ag Transaction History
Valeo Financial Advisors, LLC
- $3.97 Billion
- Q4 2024
A detailed history of Valeo Financial Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 6,765 shares of NVS stock, worth $749,967. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,765
Previous 6,701
0.96%
Holding current value
$749,967
Previous $770,000
14.55%
% of portfolio
0.02%
Previous 0.02%
Shares
30 transactions
Others Institutions Holding NVS
# of Institutions
1,493Shares Held
131MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.35 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.22 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$907 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$762 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$618 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $238B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...